These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9592200

  • 1. The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines.
    Rohde D, Hayn HK, Blatter J, Jakse G.
    Int J Oncol; 1998 Jun; 12(6):1361-6. PubMed ID: 9592200
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma.
    Rohde D, Goertz M, Blatter J, Jakse G.
    Int J Oncol; 1998 Jun; 12(6):1367-72. PubMed ID: 9592201
    [Abstract] [Full Text] [Related]

  • 3. Interferon-alpha and gemcitabine (2',2'-difluorodeoxycytidine) in adult and pediatric renal tumors.
    Rohde D, Goertz M, Hayn H, Cremer U, Jakse G.
    Int J Oncol; 1997 Sep; 11(3):623-7. PubMed ID: 21528256
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ, Pinedo HM, Veerman G, Bergman AM, Kuiper CM, Vermorken JB, van der Vijgh WJ, Peters GJ.
    Br J Cancer; 1999 Jun; 80(7):981-90. PubMed ID: 10362105
    [Abstract] [Full Text] [Related]

  • 5. Experimental and clinical efficacy of 2', 2'-difluorodeoxycytidine (gemcitabine) against renal cell carcinoma.
    Rohde D, De Mulder PH, Weissbach L, Osieka R, Blatter J, Jakse G.
    Oncology; 1996 Jun; 53(6):476-81. PubMed ID: 8960143
    [Abstract] [Full Text] [Related]

  • 6. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K, Tsukamoto T.
    Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y, Hartmann J, Horvath Z, Saiko P, Grusch M, Madlener S, Maier S, Oehler L, Fritzer-Szekeres M, Heller N, Alken RG, Krupitza G, Szekeres T.
    Cancer Lett; 2008 Feb 08; 259(2):231-9. PubMed ID: 18023527
    [Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines.
    van Moorsel CJ, Pinedo HM, Veerman G, Guechev A, Smid K, Loves WJ, Vermorken JB, Postmus PE, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):407-15. PubMed ID: 9933029
    [Abstract] [Full Text] [Related]

  • 10. Synergistic interaction between cisplatin and gemcitabine in vitro.
    Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Peters GJ.
    Clin Cancer Res; 1996 Mar 15; 2(3):521-30. PubMed ID: 9816199
    [Abstract] [Full Text] [Related]

  • 11. Interferon receptors and the caspase cascade regulate the antitumor effects of interferons on human pancreatic cancer cell lines.
    Saidi RF, Williams F, Ng J, Danquah G, Mittal VK, ReMine SG, Jacobs MJ.
    Am J Surg; 2006 Mar 15; 191(3):358-63. PubMed ID: 16490547
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
    van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):237-44. PubMed ID: 12182997
    [Abstract] [Full Text] [Related]

  • 13. Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours.
    Ruiz van Haperen VW, Veerman G, Boven E, Noordhuis P, Vermorken JB, Peters GJ.
    Biochem Pharmacol; 1994 Oct 07; 48(7):1327-39. PubMed ID: 7945430
    [Abstract] [Full Text] [Related]

  • 14. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
    Lech-Marańda E, Korycka A, Robak T.
    Eur J Haematol; 2000 Nov 07; 65(5):317-21. PubMed ID: 11092462
    [Abstract] [Full Text] [Related]

  • 15. Interaction between cisplatin and gemcitabine in vitro and in vivo.
    Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ.
    Semin Oncol; 1995 Aug 07; 22(4 Suppl 11):72-9. PubMed ID: 7481849
    [Abstract] [Full Text] [Related]

  • 16. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H, Senba H, Virgona N, Fukumoto K, Ishida T, Hagiwara H, Negishi E, Ueno K, Yamasaki H, Yano T.
    Mol Carcinog; 2007 Mar 07; 46(3):215-24. PubMed ID: 17186540
    [Abstract] [Full Text] [Related]

  • 17. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
    Konecny G, Untch M, Slamon D, Beryt M, Kahlert S, Felber M, Langer E, Lude S, Hepp H, Pegram M.
    Breast Cancer Res Treat; 2001 Jun 07; 67(3):223-33. PubMed ID: 11561768
    [Abstract] [Full Text] [Related]

  • 18. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
    Long QZ, Zhou M, Liu XG, Du YF, Fan JH, Li X, He DL.
    Anticancer Drugs; 2013 Sep 07; 24(8):810-7. PubMed ID: 23744557
    [Abstract] [Full Text] [Related]

  • 19. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
    Bouffard DY, Momparler LF, Momparler RL.
    Anticancer Drugs; 1991 Feb 07; 2(1):49-55. PubMed ID: 1958852
    [Abstract] [Full Text] [Related]

  • 20. Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures.
    Padrón JM, van Moorsel CJ, Bergman AM, Smitskamp-Wilms E, van der Wilt CL, Peters GJ.
    Anticancer Drugs; 1999 Jun 07; 10(5):445-52. PubMed ID: 10477163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.